Jubilant Ingrevia Q1 FY27 results (Apr–Jun 2026) and concall

Chemicals · Concall AI · Call held 27 Jul 2026

Company page: Jubilant Ingrevia share price, financials & guidance record

Jubilant Ingrevia Limited reported a strong Q1 FY27, achieving a 15-quarter high in revenue and significant year-on-year growth in EBITDA and PAT, driven by healthy volume growth and improved realizations across Specialty Chemicals, Nutrition & Health, and Chemical Intermediates segments. The company is progressing on its strategic initiatives, including new plant commissioning and pipeline expansion, despite some challenges related to a large CDMO contract's volume visibility and raw material price volatility.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 25.2%, net profit up 41.3% against the same quarter last year.

₹ Cr · quarterly

Line item	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	1,057	1,051	1,038	1,121	1,051 −1%	1,179 +12%	1,300 +25%
Expenses	918	905	896	985	924	1,016	1,101
EBITDA	138	147	142	135	126 −9%	163 +11%	199 +40%
Margin	13%	14%	14%	12%	12%	14%	15%
Other income	9	8	11	11	-4	9	10
Interest	12	14	13	12	12	12	17
Depreciation	40	39	41	41	45	48	51
Profit before tax	96	102	100	93	65 −32%	112 +10%	141 +41%
Tax rate	27%	27%	25%	25%	28%	23%	25%
Net profit	69	74	75	69	47 −32%	86 +16%	106 +41%
EPS	4.36	4.65	4.71	4.36	2.94	5.43	6.64

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Chemicals earnings calls